- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Roger Brito on When Providers Should Be Involved in Reimbursement Model Development
Providers should be involved in new reimbursement model development from day 1, said Roger Brito, DO, national director for oncology, Aetna.
Providers should be involved in new reimbursement model development from day 1, said Roger Brito, DO, national director for oncology, Aetna.
Transcript (slightly modified)
When a new reimbursement model is being developed, at what stage should providers become involved?
My goal is that we should be involved from day 1. I was in practice for almost 20 years before joining Aetna, and the last time that I spoke to a provider as on oncologist was when they were denying some type of care plan that I was requesting. So, this is a 360-degree change. We communicate and collaborate together. I feel that from a provider perspective and with our oncology medical home models, which parallel the oncology care model, we should work together on coming up with what the ideal payment plan is going to be, and that’s our goal.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Study Finds ASCT Similarly Safe, Effective in Older and Younger Patients With Multiple Myeloma
November 30th 2023A real-world study suggests high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is feasible for appropriately selected elderly patients, with similar results seen in older and younger patients.
Read More
